The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
BioTechUSA prepares you for the festival season with naturally derived vitamins
BioTechUSA, one of Europe’s largest dietary supplement manufacturers and distributors,…
Read more >Sport as a strategic brand experience
Today sport is way more than just a sponsorship platform:…
Read more >The BioTechUSA group was able to grow despite market challenges
The purely domestically owned BioTechUSA group has published its annual…
Read more >Related news
AM: FAO also plays a huge role in overcoming crises affecting the region
International organizations have a major role to play in overcoming…
Read more >Informal consultation of FAO European and Central Asian member countries in Hungary
International organizations have a major role to play in overcoming…
Read more >Market access, marketing, AI applications: SPAR Regions Treasures program provides tangible help for small producers
The number of high-quality, domestic products from small producers, artisan…
Read more >